Literature DB >> 21544252

All Roads Lead to Rome: Update on Rome III Criteria and New Treatment Options.

David Q Shih1, Lola Y Kwan.   

Abstract

The recently published Rome III criteria reflect current understanding of functional gastrointestinal disorders. These criteria include definitions of these conditions and their pathophysiologic subtypes and offer guidelines for their management. At the 2006 Annual Scientific Meeting of the American College of Gastroenterology, a panel of experts discussed these criteria as they pertain to irritable bowel syndrome, functional dyspepsia, and chronic constipation. This article reviews the panel's findings, highlights the differences between the Rome II and III criteria, and summarizes best treatment options currently available to practitioners and their patients.

Entities:  

Year:  2007        PMID: 21544252      PMCID: PMC3085189     

Source DB:  PubMed          Journal:  Gastroenterol Rep            Impact factor:   3.651


  68 in total

1.  Lack of objective evidence of efficacy of laxatives in chronic constipation.

Authors:  Michael P Jones; Nicholas J Talley; Guy Nuyts; Dominique Dubois
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Physician visits in the United States for constipation: 1958 to 1986.

Authors:  A Sonnenberg; T R Koch
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

3.  Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery.

Authors:  John K Marshall; Marroon Thabane; Amit X Garg; William F Clark; Marina Salvadori; Stephen M Collins
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

Review 4.  Definition and classification of irritable bowel syndrome: current consensus and controversies.

Authors:  George F Longstreth
Journal:  Gastroenterol Clin North Am       Date:  2005-06       Impact factor: 3.806

5.  GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

Authors:  N J Talley; S F Phillips; A Haddad; L J Miller; C Twomey; A R Zinsmeister; R L MacCarty; A Ciociola
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

Review 6.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.

Authors:  Jonathan Gonenne; Michael Camilleri; Irene Ferber; Duane Burton; Kari Baxter; Kian Keyashian; Joseph Foss; Bruce Wallin; Wei Du; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2005-08       Impact factor: 11.382

8.  Chloride channels in the small intestinal cell line IEC-18.

Authors:  Srisaila Basavappa; Sreesatya Raju Vulapalli; Hui Zhang; David Yule; Steven Coon; Uma Sundaram
Journal:  J Cell Physiol       Date:  2005-01       Impact factor: 6.384

9.  Outlet obstruction constipation (anismus) managed by biofeedback.

Authors:  B M Kawimbe; M Papachrysostomou; N R Binnie; N Clare; A N Smith
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

10.  Smoking, alcohol, and nonsteroidal anti-inflammatory drugs in outpatients with functional dyspepsia and among dyspepsia subgroups.

Authors:  N J Talley; A L Weaver; A R Zinsmeister
Journal:  Am J Gastroenterol       Date:  1994-04       Impact factor: 10.864

View more
  24 in total

Review 1.  Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop.

Authors:  Ricky McCullough; Jeremiah McCullough
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-17

2.  Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.

Authors:  Ayman A El-Badry; Wegdan M Abd El Wahab; Doaa A Hamdy; Alaa Aboud
Journal:  Parasitol Res       Date:  2017-11-14       Impact factor: 2.289

3.  Efficacy of biofeedback plus transanal stimulation in the management of pelvic floor dyssynergia: a randomized trial.

Authors:  F Cadeddu; F Salis; E De Luca; I Ciangola; G Milito
Journal:  Tech Coloproctol       Date:  2015-03-06       Impact factor: 3.781

4.  Pelvic floor function following ventral rectopexy versus STARR in the treatment of obstructed defecation.

Authors:  D F Altomare; A Picciariello; R Memeo; M Fanelli; R Digennaro; N Chetta; M De Fazio
Journal:  Tech Coloproctol       Date:  2018-03-28       Impact factor: 3.781

5.  Should Children With Constipation Undergo Blood Lead Level Screening?

Authors:  Vikram Kalathur Raghu; Andrew J Nowalk; Arvind I Srinath
Journal:  Clin Pediatr (Phila)       Date:  2019-02-21       Impact factor: 1.168

Review 6.  Ventral Prosthesis Rectopexy for obstructed defaecation syndrome: a systematic review and meta-analysis.

Authors:  Dimitrios K Manatakis; Nikolaos Gouvas; George Pechlivanides; Evangelos Xynos
Journal:  Updates Surg       Date:  2021-10-19

7.  Anxiety and depression are associated with increased counts and degranulation of duodenal mast cells in functional dyspepsia.

Authors:  Hai-Peng Yuan; Zhen Li; Youcan Zhang; Xiao-Pei Li; Fu-Kang Li; Yan-Qing Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Does concurrent posterior repair for an asymptomatic rectocele reduce the risk of surgical failure in patients undergoing sacrocolpopexy?

Authors:  Olivia H Chang; Emily R W Davidson; Tonya N Thomas; Marie Fidela R Paraiso; Cecile A Ferrando
Journal:  Int Urogynecol J       Date:  2020-03-07       Impact factor: 2.894

9.  Laxative use among older adults with intellectual disability: a cross-sectional observational study.

Authors:  Hadiah AlMutairi; Máire O'Dwyer; Elish Burke; Mary McCarron; Philip McCallion; Martin C Henman
Journal:  Int J Clin Pharm       Date:  2019-12-02

10.  A population pharmacokinetic-pharmacodynamic model of YH12852, a highly selective 5-hydroxytryptamine 4 receptor agonist, in healthy subjects and patients with functional constipation.

Authors:  Siun Kim; Hyun A Lee; Seong Bok Jang; Howard Lee
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.